Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Transition in Pediatric and Adolescent Hypogonadal Girls: Gynecological Aspects, Estrogen Replacement Therapy, and Contraception

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review


  1. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinguishing between hidden testes and anorchia: The role of endocrine evaluation in infancy and childhood

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Heritability of pubertal timing: detailed evaluation of specific milestones in healthy boys and girls

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Hypogonadism may be suspected if puberty is delayed. Pubertal delay may be caused by a normal physiological variant, by primary ovarian insufficiency (Turner syndrome), or reflect congenital hypogonadotropic hypogonadism (HH; genetic) or acquired HH (brain lesions). Any underlying chronic disease like inflammatory bowel disease, celiac disease, malnutrition (anorexia or orthorexia), or excessive physical activity may also result in functional HH. Thus, girls with delayed puberty should be evaluated for an underlying pathology before any treatment, including oral contraception, is initiated. Estrogen replacement is important and natural 17β-estradiol, preferably transdermally, is the preferred choice, whereas the oral route can be used as an alternative depending on patient preference and compliance. Sexual activity is often delayed in the hypogonadal adolescent girl. In the adolescent hypogonadal girl, hormone replacement therapy (HRT) most likely has been initiated at the time she becomes sexually active. If a risk of unwanted pregnancy cannot be ruled out, there is a need to consider contraception. This consideration does not contradict the principles of HRT but can be included as a part of the substitution, e.g. oral contraceptives containing 17β-estradiol or a progestogen intrauterine device combined with continuous 17β-estradiol (transdermal or oral).

Original languageEnglish
Title of host publicationTransition of Care From Childhood to Adulthood in Endocrinology, Gynecology, and Diabetes
Editors Michel Polak, Philippe Touraine
Number of pages15
Publication date2018
Publication statusPublished - 2018
SeriesEndocrine Development

    Research areas

  • Adolescent, Adult, Child, Contraception/methods, Estradiol/therapeutic use, Estrogen Replacement Therapy, Female, Hormone Replacement Therapy, Humans, Hypogonadism/congenital, Pregnancy, Puberty, Delayed/etiology, Sexual Maturation/physiology, Transition to Adult Care/organization & administration, Turner Syndrome/physiopathology, Young Adult

ID: 55540314